FindTrial
Sign In

Curosurf

DRUG4 trials

Sponsors

Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau, University of Cologne, Jean Michel Hascoet, University of Michigan

Conditions

Bronchopulmonary DysplasiaCongenital Heart DiseaseHypoplastic Left Heart SyndromeInfant, Premature, DiseasesPremature infants with Respiratory Distress Syndrome (RDS)Respiratory Distress Syndrome, Newborn

Phase 1

Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy
TerminatedNCT04181255
University of MichiganCongenital Heart Disease, Hypoplastic Left Heart Syndrome
Start: 2020-02-25End: 2020-06-12Updated: 2023-09-13

Phase 2

Single-blind randomized clinical trial in premature infants with Respiratory Distress Syndrome (RDS) eligible for treatment with exogenous surfactant identified early by lung ultrasonography.
Not yet recruitingCTIS2024-515641-42-00
Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant PauPremature infants with Respiratory Distress Syndrome (RDS)
Target: 30Updated: 2025-10-16

Phase 4

Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
CompletedNCT01039285
Jean Michel HascoetBronchopulmonary Dysplasia, Infant, Premature, Diseases, Respiratory Distress Syndrome, Newborn
Start: 2009-12-31End: 2022-06-30Updated: 2022-08-24

Unknown Phase

Surfactant Application During Spontaneous Breathing With Continuous Positive Airway Pressure (CPAP) in Premature Infants < 27 Weeks
CompletedNCT00751959
University of CologneRespiratory Distress Syndrome, Newborn
Start: 2009-04-30End: 2012-06-30Updated: 2012-07-19

Related Papers

Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age
JAMA Pediatrics2016-03-0136 citations